Search Results1-8 of  8

  • NOMURA YUMIKO ID: 9000002044513

    Department of Pediatrics, Hirosaki National Hospital (2007 from CiNii)

    Articles in CiNii:1

    • Idiopathic thrombocytopenic purpura following measlesrubella-conjugated vaccine (2007)
  • NOMURA YUMIKO ID: 9000005281513

    国立医薬品食品衛生研究所医薬品医療機器審査センター企画調整部審査情報室情報第1係 (1999 from CiNii)

    Articles in CiNii:1

    • 国内における治験数の動向(<特集>変わりゆく臨床試験) (1999)
  • NOMURA YUMIKO ID: 9000255927203

    Department of Pediatrics, Iwaki-Byoin National Sanatorium (1982 from CiNii)

    Articles in CiNii:1

    • CLINICAL STUDIES ON CEFSULODIN IN PEDIATRIC FIELD (1982)
  • NOMURA Yumiko ID: 9000004140752

    国立弘前病院小児科 (1998 from CiNii)

    Articles in CiNii:6

    • 巨大非交通性透明中隔嚢胞を伴ったFrontonasal dysplasiaの1例 (小児の神経疾患<特集>) (1975)
    • 弘前地方における25年間のジフテリア患者の推移について (1981)
    • 新生児マス・スクリ-ニングで見出された乳児一過性高TSH血症 (新生児・乳児の疾患<主題>) (1981)
  • NOMURA Yumiko ID: 9000005153569

    Faculty of Pharmaceutical Sciences, The University of Tokyo (2002 from CiNii)

    Articles in CiNii:4

    • A Chiral Ligand-Mediated Asymmetric Addition of a Lithium BHA Ester Enolate to an Aldehyde (2002)
    • Synthesis and Structure-Activity Relationship sof N-Substituted 2-[(2-Imidazolylsulfinyl)methyl]anilines as a New Class of Gastric H^+/K^+-ATPase Inhibitors (1991)
    • Synthesis and Structure-Activity Relationships of 2-(4-Benzhydryl-1-piperazinyl)-1-phenylethanols as New Calcium Blockers (1995)
  • NOMURA Yumiko ID: 9000255728704

    Department of Pediatrics, Hirosaki University School of Medicine (1978 from CiNii)

    Articles in CiNii:1

    • Myoclonic encephalopathy of infants (Kinsbourne) Report of Two Cases (1978)
  • NOMURA Yumiko ID: 9000256112738

    Department of Pediatrics, Hirosaki University School of Medicine (1978 from CiNii)

    Articles in CiNii:1

    • A Case Report of Giant Axonal Neuropathy Associated with Mental Retardation and Absence Seizures (1978)
  • NOMURA Yumiko ID: 9000290135790

    厚生労働省医薬食品局血液対策課 (2014 from CiNii)

    Articles in CiNii:1

    • Outline of the Revises of the Pharmaceutical Affairs Law (2014)
Page Top